These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 967429

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Microbiological effectiveness, pharmacokinetics and clinical use of tobramycin].
    Graber H, Arr M, Deutsch T, Ludwig E, Magyar T.
    Orv Hetil; 1980 Jan 27; 121(4):213-7. PubMed ID: 7375095
    [No Abstract] [Full Text] [Related]

  • 23. Tobramycin (Nebcin).
    Drug Ther Bull; 1977 Feb 18; 15(4):14-5. PubMed ID: 837828
    [No Abstract] [Full Text] [Related]

  • 24. In vitro bactericidal activity of allicin combined with cefoperazone, tobramycin and ciprofloxacin.
    Cai Y, Wang R, An MM, Liang BB, Fang Y.
    Int J Antimicrob Agents; 2008 Feb 18; 31(2):179-80. PubMed ID: 18083012
    [No Abstract] [Full Text] [Related]

  • 25. An aminoglycoside microarray platform for directly monitoring and studying antibiotic resistance.
    Disney MD, Barrett OJ.
    Biochemistry; 2007 Oct 09; 46(40):11223-30. PubMed ID: 17867707
    [Abstract] [Full Text] [Related]

  • 26. [Tobramycin, a new aminoglycoside antibiotic].
    Periti P, Serra E.
    G Ital Chemioter; 1973 Oct 09; 20(1-4):15-9. PubMed ID: 4156968
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Increase in gentamicin- and tobramycin-resistant Staphylococcus aureus isolates from hospital patients (author's transl)].
    Goullet P, Hieng HS.
    Nouv Presse Med; 1981 Sep 12; 10(32):2645-6, 2651-2. PubMed ID: 7279649
    [Abstract] [Full Text] [Related]

  • 31. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR, Bourget C, Mainville S, Lafleur L, Lagacé J, Montplaisir S.
    J Chemother; 1989 Jul 12; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract] [Full Text] [Related]

  • 32. Susceptibility to tobramycin determined by a modified agar dilution method with a high inoculum.
    Santanam P.
    Eur J Clin Microbiol; 1985 Dec 12; 4(6):600-1. PubMed ID: 3912181
    [No Abstract] [Full Text] [Related]

  • 33. Characterization of the tobramycin-kanamycin-neomycin resistance plasmid in Staphylococcus epidermidis.
    Hecht DW, Parisi JT.
    J Antibiot (Tokyo); 1980 Aug 12; 33(8):891-4. PubMed ID: 7429990
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synthesis of 3'-deoxy-3'-fluorokanamycins A and B active against resistant bacteria.
    Tsuchiya T, Takahashi Y, Kobayashi Y, Umezawa S, Umezawa H.
    J Antibiot (Tokyo); 1985 Sep 12; 38(9):1287-90. PubMed ID: 4066510
    [No Abstract] [Full Text] [Related]

  • 37. [Orbicin (dibekacin sulfate)].
    Hofstetter A.
    Urologe A; 1979 Nov 12; 18(6):355-7. PubMed ID: 505693
    [No Abstract] [Full Text] [Related]

  • 38. [SIR-system].
    Holm SE.
    Lakartidningen; 1978 Nov 22; 75(47):4336-7. PubMed ID: 713657
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Controlling gene expression in living cells through small molecule-RNA interactions.
    Werstuck G, Green MR.
    Science; 1998 Oct 09; 282(5387):296-8. PubMed ID: 9765156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.